为痴呆症患者提供视频会议支持小组:一个系统的叙事审查
Bethany Linder1, Helen Atherton2, John I MacArtney1
1Unit of Academic Primary Care, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Aging & mental health
|October 23, 2024
概括
视频会议同行支持小组为痴呆症患者的照顾者提供了宝贵的联系和应对策略. 虽然方便,但技术支持和频繁的会议提高了他们的有效性.
科学领域:
- 老年学是指老年学的学科.
- 数字健康数字健康
- 护理人员支持护理人员支持
背景情况:
- 痴呆症对个人及其照顾者构成重大挑战.
- 保持社会联系和支持对于管理痴呆症至关重要.
- 在线平台为可访问的支持提供了潜在的解决方案.
研究的目的:
- 系统地审查视频会议同行支持小组的影响.
- 检查这些群体中痴呆症患者及其照顾者的经历.
主要方法:
- 采用了一个叙事综合方法.
- 在2024年1月,在五个主要数据库 (MEDLINE,PsycINFO,EMBASE,CINAHL,Web of Science) 进行了搜索.
- 包括的研究包括定性,定量和混合方法研究.
主要成果:
- 16项研究符合纳入标准.
- 参与者报告了显著的好处,包括连接,建议和学习应对策略.
- 方便性是一个关键优势,尽管注意到了技术上的困难;IT支持减轻了这些问题.
结论:
- 视频会议支持小组对于痴呆症护理人员来说是有益的,特别是频繁的会议和IT支持.
- 需要进一步的研究才能充分了解痴呆症患者的好处.
相关概念视频
Self-Help Support Groups
27
Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
27
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Continuing Care
1.4K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.4K
Documentation in Long-Term and Home Healthcare Setting
873
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
873


